| Long name: |
Yellow fever virus envelope glycoprotein E Antibody |
| Also known as: |
Yellow fever virus envelope glycoprotein E Antibody |
| Category: |
Primary Antibodies |
| Conjugation: |
Unconjugated |
| Target Antigen: |
Yellow fever virus envelope glycoprotein E |
| Specificity: |
This is a highly specific antibody against Yellow fever virus envelope glycoprotein E |
| Modification(s): |
None |
| Modification site(s): |
Unmodified antibody |
| Clonality: |
Polyclonal antibody |
| Clone number: |
Polyclonal antibody |
| Concentration: |
1ug per 1ul |
| Immunogen range: |
650-700/3411 |
| Subcellular location: |
Extracellular |
| Source: |
KLH conjugated synthetic peptide derived from Yellow fever virus envelope glycoprotein E (IIVGRGDSRLTY) |
| Gene ID number: |
1502173 |
| Swiss Prot: |
P03314 |
| Tested Applications: |
IF(IHC-P), IHC-P |
| Recommended dilutions: |
IF(IHC-P)(1:50-200), IHC-P(1:100-500) |
| Cross reactivity: |
Virus |
| Cross reactive species details: |
Yellow fever virus |
| Background of the target antigen: |
After cleavage by host furin, After cleavage of prM, Envelope protein E binding to host cell surface receptor is followed by virus internalization through clathrin-mediated endocytosis, Envelope protein E is subsequently involved in membrane fusion between virion and host late endosomes, NS2A-NS2B, NS2B-NS3, NS3 RNA helicase binds RNA and unwinds dsRNA in the 3' to 5' direction (By similarity), NS3 serine protease, NS3-NS4A, NS4A-2K and NS4B-NS5, NTPase and RNA helicase, Non-structural protein 1 is involved in virus replication and regulation of the innate immune response, Non-structural protein 2A may be involved viral RNA replication and capsid assembly, Non-structural protein 2B is a required cofactor for the serine protease function of NS3, Non-structural protein 4A induces host endoplasmic reticulum membrane rearrangements leading to the formation of virus-induced membranous vesicles hosting the dsRNA and polymerase, Serine protease NS3 displays three enzymatic activities: serine protease, Synthesized as a homodimer with prM which acts as a chaperone for envelope protein E, The capsid encapsulates the genomic RNA (By similarity), envelope protein E dissociate from small envelope protein M and homodimerizes (By similarity), functioning as a replication complex, in association with NS2B, performs its autocleavage and cleaves the polyprotein at dibasic sites in the cytoplasm: C-prM, prM acts as a chaperone for envelope protein E during intracellular virion assembly by masking and inactivating envelope protein E fusion peptide, prM is matured in the last step of virion assembly, presumably to avoid catastrophic activation of the viral fusion peptide induced by the acidic pH of the trans-Golgi network, the pr peptide is released in the extracellular medium and small envelope protein M and envelope protein E homodimers are dissociated (By similarity), Capsid protein C self-assembles to form an icosahedral capsid about 30 nm in diameter |
| Purification method: |
This antibody was purified via Protein A |
| Storage conditions: |
50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA |
| Synonym names: |
Genome polyprotein |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24° |
| Gene target: |
fever virus envelope glycoprotein E |
| Short name: |
fever virus envelope glycoprotein E Antibody |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
Yellow fever virus envelope glycoprotein E (Antibody to) |
| Alternative technique: |
antibodies |